Wave life sciences to present at the 2023 virtual svb securities global biopharma conference

Cambridge, mass., feb. 09, 2023 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that paul bolno, md, mba, president and chief executive officer, is scheduled to participate in a fireside chat at the svb securities global biopharma conference at 10:00 a.m. et on thursday, february, 16, 2023.
WVE Ratings Summary
WVE Quant Ranking